基因組學服務市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Genomics Services Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年03月25日 | 出版商:

Global Market Insights Inc. | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球基因組學服務市場價值 85 億美元，預計 2025 年至 2034 年的複合年成長率為 11.5%。由於遺傳疾病盛行率不斷上升以及對個人化醫療的日益重視，市場正在不斷擴大。隨著對遺傳學理解的不斷深入，對基因組服務的需求正在激增，尤其是精準醫療在治療方案中的日益融合。在基因檢測和基因定序技術的進步推動下，全球醫療保健領域正在轉向更個人化的方法。這些發展為早期診斷、針對性治療和改善患者預後鋪平了道路。世界各國政府和私人組織正在大力投資基因組研究，越來越注重提高診斷準確性和開發新療法。隨著精準醫療的興起，基因組服務在研究、臨床診斷和治療開發中變得越來越不可或缺，為未來十年市場實現顯著成長奠定了基礎。

包括下一代定序（NGS）在內的尖端技術的發展是推動基因組學服務市場向前發展的關鍵驅動力。生物技術新創公司和成熟的行業領導者正在積極投資研發，以改進這些技術並增強其能力。定序成本的下降進一步加速了NGS的採用，使得研究人員和臨床醫生能夠快速且準確地對DNA和RNA進行定序。與傳統方法相比，該技術可以在很短的時間內識別基因突變或變異，使其成為研究和臨床診斷的首選。 2023 年，光是次世代定序領域就創造了 27 億美元的收入，凸顯了其在推動基因組研究和個人化醫療方面的關鍵作用。此外，其他突出的服務類型包括基因分型、微陣列和桑格測序，每種服務類型都透過提供針對不同研究和臨床需求的專門解決方案來促進市場的成長。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	85億美元
預測值	250億美元
複合年成長率	11.5%

基因組學服務市場分為研究和診斷，其中研究部分在 2024 年佔據 63.6% 的市場。政府和私營部門對基因組研究的投資不斷增加，推動了這一領域的成長。學術機構和生物技術公司正在利用基因組服務來研究基因結構、功能和變異，促進新療法的發現並提高對遺傳疾病的理解。基因組學在藥物發現和臨床研究中的快速應用凸顯了基因組服務在轉變現代醫療保健方面日益成長的重要性。

美國基因組學服務市場預計也將經歷強勁成長，到 2034 年將維持 11.5% 的複合年成長率。這一成長得益於政府對基因組學研究的大量資助、先進研究設施的可用性以及公眾對精準醫療的認知不斷提高。美國繼續引領全球基因組學領域，其完善的基礎設施以及公共和私人實體之間的密切合作促進了基因組服務的快速發展。對基因組研究的日益重視以及精準醫療與臨床工作流程的整合強化了基因組學在醫療保健和藥物開發中的重要性，為未來幾年市場持續成長奠定了基礎。

產業生態系統分析
產業衝擊力
- 成長動力
  - 基因組學技術進步
  - 遺傳性疾病盛行率上升
  - 基因組學在專科或個人化醫療的應用日益增多
- 產業陷阱與挑戰
  - 缺乏訓練有素的基因組學專業人員
  - 建立基因組實驗室的成本高昂
成長潛力分析
監管格局
未來市場趨勢
波特的分析
PESTEL分析

第4章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
策略儀表板

第5章：市場估計與預測：按服務類型，2021-2034 年

主要趨勢
下一代定序
基因分型
微陣列
桑格定序
其他服務

第6章：市場估計與預測：按應用，2021-2034

主要趨勢
研究
診斷

第7章：市場估計與預測：依最終用途，2021-2034

主要趨勢
研究機構
診斷中心
製藥和生物技術公司
合約研究組織（CRO）
其他最終用途

第8章：市場估計與預測：按地區，2021-2034

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第9章：公司簡介

23andMe
Agilent Technologies
BGI Genomics
Bio Rad Laboratories
Color Genomics
Danaher
Eurofins Scientific
F. Hoffmann-La Roche
GE Healthcare
GENEWIZ (Azenta)
Illumina
LGC
Macrogen
IQVIA
QIAGEN

簡介目錄

Product Code: 5811

The Global Genomics Services Market, valued at USD 8.5 billion in 2024, is projected to grow at a CAGR of 11.5% from 2025 to 2034. The market is expanding due to the increasing prevalence of genetic disorders and the rising emphasis on personalized medicine. As the understanding of genetics deepens, the demand for genomic services is surging, particularly with the growing integration of precision medicine in treatment protocols. The global healthcare landscape is witnessing a shift toward more personalized approaches driven by advancements in genetic testing and gene sequencing technologies. These developments are paving the way for early diagnosis, targeted treatments, and improved patient outcomes. Governments and private organizations worldwide are investing heavily in genomic research, with an increasing focus on enhancing diagnostic accuracy and developing new therapies. As precision medicine gains traction, genomic services are becoming indispensable in research, clinical diagnostics, and therapeutic development, positioning the market for significant growth over the next decade.

The development of cutting-edge technologies, including next-generation sequencing (NGS), is a critical driver propelling the genomics services market forward. Biotechnology startups and established industry leaders are actively investing in research and development to refine these technologies and enhance their capabilities. The declining cost of sequencing has further accelerated the adoption of NGS, allowing researchers and clinicians to sequence DNA and RNA quickly and accurately. This technology can identify gene mutations or variations in a fraction of the time compared to traditional methods, making it a preferred choice in both research and clinical diagnostics. In 2023, the next-generation sequencing segment alone generated USD 2.7 billion, underscoring its pivotal role in advancing genomic research and personalized medicine. Additionally, other prominent service types include genotyping, microarrays, and Sanger sequencing, each contributing to the market's growth by offering specialized solutions tailored to different research and clinical needs.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$8.5 Billion
Forecast Value	$25 Billion
CAGR	11.5%

The genomics services market is divided between research and diagnostics, with the research segment accounting for 63.6% of the market share in 2024. The increasing investments from both government and private sectors in genomic research are driving the growth of this segment. Academic institutions and biotechnology companies are leveraging genomic services to study gene structure, function, and variation, facilitating the discovery of novel therapies and improving the understanding of genetic disorders. The rapid adoption of genomics in drug discovery and clinical research highlights the growing importance of genomic services in transforming modern healthcare.

The U.S. Genomics Services Market is also expected to witness robust growth, maintaining a CAGR of 11.5% through 2034. This growth is fueled by substantial government funding for genomic research, the availability of advanced research facilities, and increasing public awareness of precision medicine. The United States continues to lead the global genomics landscape, with its well-established infrastructure and strong collaborations between public and private entities contributing to the rapid advancement of genomic services. The growing emphasis on genomic research and the integration of precision medicine into clinical workflows reinforce the significance of genomics in healthcare and drug development, positioning the market for sustained growth in the coming years.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Technological advancements in genomics
  - 3.2.1.2 Rising prevalence of genetic disorders
  - 3.2.1.3 Increasing usage of genomics in specialized or personalized medicines
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Shortage of trained genomics professionals
  - 3.2.2.2 High costs of establishing genomic laboratories
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Service Type, 2021-2034 ($ Mn)

5.1 Key trends
5.2 Next generation sequencing
5.3 Genotyping
5.4 Microarray
5.5 Sanger sequencing
5.6 Other services

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 ($ Mn)

6.1 Key trends
6.2 Research
6.3 Diagnostics

Chapter 7 Market Estimates and Forecast, By End Use, 2021-2034 ($ Mn)

7.1 Key trends
7.2 Research institutes
7.3 Diagnostic centers
7.4 Pharmaceutical and biotechnological companies
7.5 Contract research organization (CROs)
7.6 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE